E EMMECELL
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 02 Feb 2022)
What this means for you
Registered since 04 Oct 2016. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 86627969
- Registration number
- 5055545
- Mark type
- Design + words
- Filed
- 13 May 2015
- Published for opposition
- 29 Mar 2016
- Registered
- 04 Oct 2016
- Attorney of record
- Erik M. Pelton
Goods and services
- Class 042 — Scientific and technological services: Consulting in the field of scientific research relating to biotechnology, pharmaceuticals, ophthalmology, cellular and molecular biology and cell therapy; Research and development for others in the field of biotechnology, pharmaceuticals, ophthalmology, cellular and molecular biology, cell therapy
- Class 044 — Medical, beauty and agricultural services: Consulting in the fields of ophthalmology and health as it relates to cell therapy
Owner
- Emmetrope Ophthalmics LLC, Menlo Park, CA, US
- Emmetrope Ophthalmics LLC, Key Biscane, FL, US
- Emmetrope Ophthalmics LLC, Key Biscane, FL, US
Prosecution history
- 04 Oct 2025 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 02 Feb 2022 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 02 Feb 2022 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 01 Feb 2022 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 15 Oct 2021 — TEAS SECTION 8 & 15 RECEIVED
- 04 Oct 2021 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 27 Jun 2017 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 27 Jun 2017 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 04 Oct 2016 — REGISTERED-PRINCIPAL REGISTER
- 01 Sept 2016 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 31 Aug 2016 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 29 Aug 2016 — STATEMENT OF USE PROCESSING COMPLETE
- 03 Aug 2016 — USE AMENDMENT FILED
- 27 Aug 2016 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 03 Aug 2016 — TEAS STATEMENT OF USE RECEIVED